Meeting report of the 10th European AIDS Conference (EACS) 17-20 November 2005.
Chew
Nicholas
N
Mater University Hospital, University College Dublin, Ireland.
Lambert
John S
JS
D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use; D065100:CCR5 Receptor Antagonists; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000188:drug therapy; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D007494:Ireland; D009169:Mycobacterium tuberculosis; D019713:Receptors, CCR5 / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy
D019380:Anti-HIV Agents; D000995:Antitubercular Agents; D065100:CCR5 Receptor Antagonists; D007376:Interleukin-2; D019713:Receptors, CCR5; D018894:Reverse Transcriptase Inhibitors